The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksWAND.L Regulatory News (WAND)

  • There is currently no data for WAND

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Successful Shareholder General Meeting Next Steps

9 Jun 2023 07:00

RNS Number : 1798C
WANdisco Plc
09 June 2023
 

9 June 2023

WANdisco plc 

 

 ("WANdisco" or the "Company") 

 

Successful Shareholder General Meeting Next Steps

 

WANdisco (LSE: WAND), the data activation platform is pleased to confirm that, following the passing of all resolutions proposed at the Shareholder General Meeting ("GM") on 6 June 2023, the Company will continue with the next phase of its fundraising plan (the "Proposed Fundraise") to raise up to $30 million and lift the current suspension of the Company's shares.

 

The Proposed Fund Raise

Following the RNS titled 'Exploring Funding Options' published on 15 May 2023 (https://polaris.brighterir.com/public/wandisco/news/rns/story/w03zolw), management completed over 45 meetings covering a large majority of the shareholder base as part of a consultative process to assess the potential for the Proposed Fund Raise. As subsequently announced, 97.7% of votes cast at the 6 June 2023 General Meeting were in favour of the resolutions set out in the Circular (https://polaris.brighterir.com/public/wandisco/news/rns_widget/story/xlen3pw).

 

With advice from the Company's Nominated Advisor and joint brokers, and in consultation with other advisers, a range of options that emerged during shareholder consultation are being actively examined in detail and evaluated against certain criteria. Those criteria include:

 

· equality of treatment for all shareholders;

· the effect of any fundraising activity on the underlying value of the outstanding equity (including any requirement for covenants and refinancing risk as appropriate);

· the ability to execute a capitalisation in the timescale available;

· regulatory constraints;

· completion of the FY22 audit sign off as a going concern;

· minimisation of dilution; and

· an orderly readmission of the Company's shares to trading on AIM.

 

Lifting of the Share Suspension

The Board will seek to have the share suspension lifted upon completion of the Proposed Fundraise and when audited accounts for the year to 31 December 2022 have been released. This is currently expected to be on or around 30 June 2023. Re-admission of the shares to trading on AIM will provide liquidity for shareholders as well as help to further restore confidence in the Company for its partners, customers, and employees, and allow the Company to progress with its Turnaround Plan.

 

Turnaround Plan

Management is progressing the 'Turnaround Plan' outlined on 15 May 2023. Further details will be shared with investors during an investor roadshow, planned to commence shortly. This roadshow will cover areas such as WANdisco's target market size; its technology and product differentiation; the Company's go-to-market strategy and structure; selling methodology and sales governance processes; improvements in disclosure; organisational structure; corporate governance and the Board's future ambitions for the Company.

 

Investigation Procedure

The Company continues to liaise and cooperate with the authorities in relation to the issues identified, including providing access to the findings of the independent investigation already undertaken.

Further to the Independent Investigation Update already released, the independent investigation findings confirm that there were eight companies from which Purchase Orders transpired to be false. The findings of the independent investigation confirm that there are no recent contracts, revenues, Proofs of Concept, technical engagements or sales relationships between any of these eight companies and WANdisco.

 

Change of Name

At the 2023 Annual General Meeting of the Company, it is anticipated that one of the proposed resolutions will relate to a change of the Company's name.

 

The change to the company name is part of a broader update to the Company's overall brand to best reflect the values and vision embodied in the Turnaround Plan, including but not limited to improvements in disclosure, governance, and the Board's future ambitions for the Company.

 

Further details on the proposed change will be shared as appropriate and confirmation of the date of the Annual General Meeting will be made in due course.

 

 

For further information, please contact:

 

FTI Consulting

 

+44 (0)20 3727 1137

Rob Mindell / Kwaku Aning / Tom Blundell / Matt Dixon

 

 

Stifel (Nomad and Joint Broker)

 

+44 (0)20 7710 7600

Fred Walsh / Richard Short / Tom Marsh

 

 

Liberum (Joint Broker)

 

Max Jones 

 

+44 (0)20 3100 2000

 

 

About WANdisco

WANdisco is the data activation platform for accelerating digital transformation at scale. WANdisco makes infinite data actionable across clouds and enterprises in real time. WANdisco customers unleash the business value of the cloud with zero downtime, data loss, or disruption to fuel AI and machine learning, create new services, and transform businesses. For more information about WANdisco, visit  www.wandisco.com

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCUWSRROKUNRUR
Date   Source Headline
4th Oct 20237:00 amRNSWANdisco plc rebrands as Cirata plc
22nd Sep 20236:24 pmRNSHolding(s) in Company
11th Sep 20237:00 amRNSInterim results
7th Sep 20233:30 pmRNSNotice of Results
30th Aug 20236:04 pmRNSResult of Annual General Meeting
18th Aug 20236:05 pmRNSBlock Admission Notification
16th Aug 20238:07 amRNSGM Signs Multi-Project Contract with WANdisco
31st Jul 20237:00 amRNSHolding(s) in Company
28th Jul 20233:25 pmRNSHolding(s) in Company
26th Jul 20237:00 amRNSBoard Changes
25th Jul 20237:30 amRNSRestoration - WANdisco plc
25th Jul 20237:00 amRNSConfirmation of Exchange Rate
24th Jul 202310:45 amRNSResult of GM
17th Jul 20235:00 pmRNSPosting of Annual Report and Accounts
12th Jul 20231:45 pmRNSPublication of Annual Report and Accounts
11th Jul 20237:00 amRNSContract Win
10th Jul 20237:00 amRNSContract Renewal
7th Jul 20237:00 amRNSConfirmation of Fundraise
5th Jul 20236:29 pmRNSPublication of Notice of General Meeting
5th Jul 202311:30 amRNSUpdate to Fundraise Timetable
4th Jul 20237:00 amRNSResult of Fundraising
3rd Jul 202312:00 pmRNSLaunch of Fundraise
29th Jun 20237:00 amRNSPreliminary Unaudited Results FY22
28th Jun 202311:51 amRNSUpdate on Timing of Results and Equity Issue
26th Jun 20233:30 pmRNSTurnaround Plan Momentum
26th Jun 20237:00 amRNSWANdisco Signs New Agreement with Accenture
15th Jun 20239:46 amRNSFCA investigation timeline update
9th Jun 20237:00 amRNSSuccessful Shareholder General Meeting Next Steps
6th Jun 20233:49 pmRNSResult of General Meeting
19th May 20236:22 pmRNSPublication of Circular and Notice of GM
19th May 20236:04 pmRNSBoard Change
15th May 20237:00 amRNSExploring Funding Options
9th May 20235:30 pmRNSWANdisco
9th May 20237:00 amRNSAppointment of Interim Chief Executive
4th May 20237:00 amRNSOrganisation Update
28th Apr 20237:00 amRNSIndependent Investigation Update
20th Apr 20237:00 amRNSFCA Investigation
5th Apr 20237:00 amRNSExecutive Chair Appointment Confirmation
4th Apr 20237:00 amRNSContract Renewals
3rd Apr 20237:00 amRNSBoard Change and Investigation Update
22nd Mar 20237:00 amRNSAppointment of Interim Chair
10th Mar 20239:31 amRNSIndependent Investigation Appointment
9th Mar 20237:30 amRNSSuspension - WANdisco plc
9th Mar 20237:00 amRNSTrading Revision
7th Mar 20237:00 amRNSAppointment of Joint Broker
6th Mar 20237:00 amRNSResponse to press speculation
1st Mar 20238:16 amRNSTotal Voting Rights
1st Feb 20234:05 pmRNSTotal Voting Rights
24th Jan 20237:00 amRNS$9m industrial and consumer goods contract win
11th Jan 20237:00 amRNSFY22 Trading Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.